Publications

• Evaluation of Access Disparities to Biologic Disease-Modifying Antirheumatic Drugs in Rural and Urban Communities.
  Cureus Volume: 14 Page(s): e26448
  06/01/2022 Authors: Peterman NJ; Vashi A; Govan D; Bhatia A; Vashi T; Kaptur B; Yeo EG; Gizinski A
• Could knee inflammatory synovitis be induced by pembrolizumab?
  J Oncol Pharm Pract Volume: 24 Page(s): 389 - 392
  07/01/2018 Authors: Mahmoud F; Wilkinson JT; Gizinski A; Viswamitra S; Gokden N; Vander Schilden J
• A Primer on Rheumatologic Laboratory Tests: What They Mean and When to Order Them.
  Prim Care Volume: 45 Page(s): 181 - 191
  06/01/2018 Authors: Patel L; Gizinski AM
• T cell subsets and their role in the pathogenesis of rheumatic disease.
  Curr Opin Rheumatol Volume: 26 Page(s): 204 - 210
  03/01/2014 Authors: Gizinski AM; Fox DA
• Neutrophil extracellular traps are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis
  Volume: 190
  05/01/2013 Authors: Carmona-Rivera C; Khandpur R; Vivekanandan-Giri A; Gizinski A; Yalavarthi S; Knight J; Friday S; Li S; Patel R; Thompson P
• NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.
  Sci Transl Med Volume: 5 Page(s): 178ra40
  03/27/2013 Authors: Khandpur R; Carmona-Rivera C; Vivekanandan-Giri A; Gizinski A; Yalavarthi S; Knight JS; Friday S; Li S; Patel RM; Subramanian V
• A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice.
  Exp Lung Res Volume: 38 Page(s): 55 - 66
  03/01/2012 Authors: Keith RC; Powers JL; Redente EF; Sergew A; Martin RJ; Gizinski A; Holers VM; Sakaguchi S; Riches DWH
• N--benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.
  J Immunol Volume: 186 Page(s): 4396 - 4404
  04/01/2011 Authors: Willis VC; Gizinski AM; Banda NK; Causey CP; Knuckley B; Cordova KN; Luo Y; Levitt B; Glogowska M; Chandra P
• Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets.
  Best Pract Res Clin Rheumatol Volume: 24 Page(s): 463 - 477
  08/01/2010 Authors: Gizinski AM; Fox DA; Sarkar S
• Cell-cell interactions in rheumatoid arthritis synovium.
  Rheum Dis Clin North Am Volume: 36 Page(s): 311 - 323
  05/01/2010 Authors: Fox DA; Gizinski A; Morgan R; Lundy SK
• Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA.
  Clin Rheumatol Volume: 28 Page(s): 611 - 613
  05/01/2009 Authors: Gizinski AM; Mascolo M; Loucks JL; Kervitsky A; Meehan RT; Brown KK; Holers VM; Deane KD
• Treatment with Cl-amidine, a peptidyl arginine deiminase (PAD) inhibitor, significantly reduces collagen-induced arthritis (CIA)
  Volume: 182
  04/01/2009 Authors: Willis VC; Gizinski A; Banda NK; Knuckley B; Cordova K; Luo Y; Causey CP; Levitt B; Glogowska M; Benbarak M
• Rheumatoid arthritis-specific autoantibodies are present in patients with interstitial lung disease in the absence of arthritis.
  Volume: 55 Page(s): S144 - S144
  01/01/2007 Authors: Gizinski AM; Kervitsky D; Meehan R; Brown KK; Holers VM; Deane KD
• Rheumatoid arthritis (RA)-specific autoantibodies are present in patients with interstitial lung disease (ILD) in the absence of arthritis.
  Volume: 54 Page(s): 4068 - 4068
  12/01/2006 Authors: Gizinski AM; Kervitsky D; Meehan R; Brown K; Holers VM; Deane K